Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE Study: Ibandronate With or Without Capecitabine in Elderly Early Breast Cancer
NCT00196859Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Jun 2004
- Primary completion
- Jan 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in breast cancer, sponsored by GBG Forschungs. Started Jun 2004; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00196859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196859.